Carregant...
Problems With Public Reporting of Cancer Quality Outcomes Data
The authors say public reporting of even the most well-defined end points—survival after treatment—can be misleading when used to compare outcomes across providers, and these data can suffer from patient-selection and treatment-intensity biases.
Guardat en:
| Publicat a: | J Oncol Pract |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Clinical Oncology
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5795653/ https://ncbi.nlm.nih.gov/pubmed/24839285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2014.001405 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|